Somativa is a modern hybrid-indica cultivar developed through the crossbreeding of Big Skunk Korean and Jack Herer. This genetic pairing brings together complex lineage traits to produce a plant that requires moderate skill to cultivate. Growers can expect a high yield from this variety, which matures within a flowering period of 63 days and is suitable for both indoor and outdoor environments. The genetic influence of this cultivar is further evidenced by its role as a parent to G13 Haze Somativa, marking its place in established breeding programs.

The chemical profile of Somativa displays a diverse range of secondary metabolites, led by a dominant concentration of terpinolene, followed closely by myrcene and caryophyllene. The full terpene spectrum includes, in descending order of prevalence, ocimene, limonene, humulene, beta-pinene, linalool, pinene, and alpha-terpinene. This specific arrangement of aromatic compounds defines the sensory profile, creating a nuanced interaction of spicy, woody, and herbal notes that characterize the cultivar’s presence.

As a THC-dominant variety, Somativa is primarily sought for its ability to induce states of relaxation, calm, and focus. These effects make the strain a functional choice for patients addressing symptoms of pain, stress, and sleep difficulties. By balancing sedative qualities with mental clarity, it offers a versatile profile for those managing specific health-related use cases. Its legacy continues through its notable offspring, reflecting a consistent transmission of its hybrid-indica characteristics to future generations.